Catherine Spina
Columbia New York Presbyterian
Radiation Oncology

Predoctoral Trainee (previously held)
Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences
Molecular and Translational Medicine

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Rayn K, Deutsch I, Jeffers B, Lee A, Lavrova E, Gallitto M, Mayeda M, Hwang M, Yu J, Spina C, Koutcher L. Multiparametric MRI as a Predictor of PSA Response in Patients Undergoing Stereotactic Body Radiation Therapy for Prostate Cancer. Adv Radiat Oncol. 2024 Mar; 9(3):101408. PMID: 38304110; PMCID: PMC10831170; DOI: 10.1016/j.adro.2023.101408;
  2. Wang YF, Price MJ, Elliston CD, Munbodh R, Spina CS, Horowitz DP, Kachnic LA. Enhancing Safety in AI-Driven Cone Beam CT-based Online Adaptive Radiation Therapy: Development and Implementation of an Interdisciplinary Workflow. Adv Radiat Oncol. 2024 Mar; 9(3):101399. PMID: 38292890; PMCID: PMC10823112; DOI: 10.1016/j.adro.2023.101399;
  3. Ager CR, Zhang M, Chaimowitz M, Bansal S, Tagore S, Obradovic A, Jugler C, Rogava M, Melms JC, McCann P, Spina C, Drake CG, Dallos MC, Izar B. KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response. J Immunother Cancer. 2023 Sep; 11(9). PMID: 37657842; PMCID: PMC10476134; DOI: 10.1136/jitc-2023-006782;
  4. Chen L, Shi V, Wang S, Sun L, Freeman R, Yang J, Inkman MJ, Ghosh S, Ruiz F, Jayachandran K, Huang Y, Luo J, Zhang J, Cosper P, Luke CJ, Spina CS, Grigsby PW, Schwarz JK, Markovina S. SCCA1/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine production. J Clin Invest. 2023 Aug 01; 133(15). PMID: 37279067; PMCID: PMC10378164; DOI: 10.1172/JCI163841;
  5. Spina CS, DeLaney TF. The Significance of a Pathologic Complete Response in Patients With Soft Tissue Sarcoma. JAMA Oncol. 2023 May 01; 9(5):619-621. PMID: 36995719
  6. Ager CR, Zhang M, Chaimowitz M, Bansal S, Obradovic A, Rogava M, Melms JC, McCann P, Spina C, Drake CG, Dallos MC, Izar B. KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response. bioRxiv. 2023 Jan 02. PMID: 36711647; PMCID: PMC9881861; DOI: 10.1101/2023.01.01.522340;
  7. Alì A, Leibowitz D, Bhatt N, Doubrovin M, Spina CS, Bates-Pappas GE, Taub RN, McKiernan JM, Mintz A, Molotkov A. Preliminary efficacy of [90Y]DOTA-biotin-avidin radiotherapy against non-muscle invasive bladder cancer. Eur J Nucl Med Mol Imaging. 2023 Feb; 50(3):692-700. PMID: 36350400
  8. Spina CS, Drake CG. Mechanisms of Immune Modulation by Radiation. Semin Radiat Oncol. 2021 07; 31(3):205-216. PMID: 34090647
  9. Hwang ME, Mayeda M, Shaish H, Elliston CD, Spina CS, Wenske S, Deutsch I. Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function. Br J Radiol. 2021 Mar 01; 94(1119):20200433. PMID: 33586999; PMCID: PMC8011244; DOI: 10.1259/bjr.20200433;
  10. Bender DA, Heilbroner SP, Wang TJC, Shu CA, Hyde B, Spina C, Cheng SK. Increased rates of immunosuppressive treatment and hospitalization after checkpoint inhibitor therapy in cancer patients with autoimmune disease. J Immunother Cancer. 2020 12; 8(2). PMID: 33303578; PMCID: PMC7733208; DOI: 10.1136/jitc-2020-001627;
Showing 10 of 29 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 29 publications over 13 distinct years, with a maximum of 6 publications in 2023


Contact for Mentoring:
Spina's Networks
Click the "See All" links for more information and interactive visualizations
Similar People